Biotechnology
The Biotechnology industry has a total of 594 stocks, with a combined market cap of $1.32 trillion and total revenue of $120.81 billion.
Market Cap
1.32T
Revenue
120.81B
Profits
-35.06B
PE Ratio
n/a
Profit Margin
-29.02%
Dividend Yield
0.04%
594 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 137.94B | 2.53% | 1,022,039 | 12.95B |
| 2 | MRNA | Moderna, Inc. | 98.85B | 8.39% | 9,677,278 | 2.23B |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 94.46B | -3.29% | 815,976 | 16.90B |
| 4 | ARGX | argenx SE | 58.53B | 2.32% | 497,531 | 5.92B |
| 5 | ONC | BeOne Medicines AG | 43.21B | 7.05% | 471,233 | 6.13B |
| 6 | RVMD | Revolution Medicines, Inc. | 42.88B | 3.01% | 1,530,657 | - |
| 7 | RPRX | Royalty Pharma plc | 38.47B | 0.77% | 2,073,727 | 2.62B |
| 8 | GMAB | Genmab A/S | 31.60B | -1.58% | 3,009,023 | 4.13B |
| 9 | ROIV | Roivant Sciences Ltd. | 27.50B | 5.62% | 7,486,609 | 7.53M |
| 10 | INCY | Incyte Corporation | 24.96B | 4.12% | 1,215,610 | 6.01B |
| 11 | INSM | Insmed Incorporated | 23.79B | 3.82% | 1,323,715 | 1.52B |
| 12 | BNTX | BioNTech SE | 22.58B | 3.40% | 949,797 | 2.75B |
| 13 | ALNY | Alnylam Pharmaceuticals, Inc. | 21.61B | 0.92% | 2,117,677 | 5.01B |
| 14 | EXEL | Exelixis, Inc. | 17.75B | 0.62% | 1,585,057 | 2.50B |
| 15 | ASND | Ascendis Pharma A/S | 16.70B | 1.65% | 318,780 | 1.20B |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 15.05B | 0.94% | 468,791 | 4.72B |
| 17 | BBIO | BridgeBio Pharma, Inc. | 14.91B | 3.36% | 3,532,914 | 945.54M |
| 18 | HALO | Halozyme Therapeutics, Inc. | 14.80B | 1.38% | 982,605 | 1.66B |
| 19 | SMMT | Summit Therapeutics Inc. | 12.79B | 1.20% | 2,815,251 | - |
| 20 | KYMR | Kymera Therapeutics, Inc. | 11.46B | 5.63% | 951,908 | 102.24M |
| 21 | TECH | Bio-Techne Corporation | 11.42B | 0.19% | 2,529,121 | 1.22B |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.93B | 1.49% | 1,315,108 | 3.66B |
| 23 | PCVX | Vaxcyte, Inc. | 10.17B | 6.22% | 1,181,478 | - |
| 24 | PTGX | Protagonist Therapeutics, Inc. | 9.22B | 1.60% | 265,261 | 281.99M |
| 25 | KRYS | Krystal Biotech, Inc. | 9.20B | 1.76% | 208,669 | 470.03M |
| 26 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.17B | 0.15% | 1,803,393 | 1.43B |
| 27 | CAI | Caris Life Sciences, Inc. | 9.11B | -1.86% | 1,897,641 | 989.61M |
| 28 | SYRE | Spyre Therapeutics, Inc. | 9.08B | -2.09% | 896,498 | - |
| 29 | IBRX | ImmunityBio, Inc. | 9.02B | 2.65% | 5,614,523 | 165.79M |
| 30 | CYTK | Cytokinetics, Incorporated | 8.83B | 1.93% | 1,391,106 | 67.67M |
| 31 | TGTX | TG Therapeutics, Inc. | 8.74B | 1.47% | 1,074,730 | 799.54M |
| 32 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.67B | 3.08% | 765,921 | 669.50M |
| 33 | TWST | Twist Bioscience Corporation | 8.62B | -2.07% | 1,055,298 | 431.80M |
| 34 | CORT | Corcept Therapeutics Incorporated | 8.29B | -6.37% | 1,502,977 | 963.65M |
| 35 | PRAX | Praxis Precision Medicines, Inc. | 7.91B | 0.96% | 175,598 | 7.46M |
| 36 | ABVX | ABIVAX Société Anonyme | 7.81B | 1.04% | 457,164 | 5.33M |
| 37 | AXSM | Axsome Therapeutics, Inc. | 7.19B | -2.08% | 479,583 | 865.27M |
| 38 | IONS | Ionis Pharmaceuticals, Inc. | 6.63B | -1.32% | 1,807,826 | 874.09M |
| 39 | ORKA | Oruka Therapeutics, Inc. | 6.61B | 0.33% | 420,397 | - |
| 40 | LGND | Ligand Pharmaceuticals Incorporated | 6.33B | 1.01% | 95,797 | 253.83M |
| 41 | KOD | Kodiak Sciences Inc. | 6.30B | 1.54% | 565,582 | - |
| 42 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.27B | 5.38% | 2,671,354 | 280.75M |
| 43 | BLTE | Belite Bio, Inc | 6.17B | 0.63% | 59,925 | - |
| 44 | MIRM | Mirum Pharmaceuticals, Inc. | 6.14B | 8.64% | 651,218 | 670.78M |
| 45 | IMVT | Immunovant, Inc. | 6.08B | 1.41% | 503,219 | - |
| 46 | CGON | CG Oncology, Inc. | 5.82B | 2.49% | 622,306 | 6.23M |
| 47 | PTCT | PTC Therapeutics, Inc. | 5.74B | 0.92% | 692,459 | 1.16B |
| 48 | MANE | Veradermics, Incorporated | 5.60B | 0.34% | 356,380 | - |
| 49 | SRRK | Scholar Rock Holding Corporation | 5.59B | 4.30% | 837,121 | - |
| 50 | COGT | Cogent Biosciences, Inc. | 5.40B | 0.10% | 1,270,568 | - |
| 51 | ERAS | Erasca, Inc. | 5.15B | 0.61% | 1,866,023 | - |
| 52 | CRSP | CRISPR Therapeutics AG | 5.02B | 3.86% | 876,479 | 25.17M |
| 53 | TVTX | Travere Therapeutics, Inc. | 4.88B | 4.72% | 1,696,501 | 651.03M |
| 54 | DNTH | Dianthus Therapeutics, Inc. | 4.70B | 1.69% | 509,497 | 1.90M |
| 55 | LEGN | Legend Biotech Corporation | 4.42B | 6.10% | 2,035,968 | 1.27B |
| 56 | DFTX | Definium Therapeutics, Inc. | 4.38B | -2.42% | 948,641 | - |
| 57 | ARQT | Arcutis Biotherapeutics, Inc. | 4.25B | 5.59% | 1,040,361 | 463.98M |
| 58 | EWTX | Edgewise Therapeutics, Inc. | 4.11B | 0.45% | 394,158 | - |
| 59 | IOVA | Iovance Biotherapeutics, Inc. | 3.96B | -1.08% | 10,943,406 | 324.97M |
| 60 | ABCL | AbCellera Biologics Inc. | 3.90B | -1.31% | 1,751,069 | 66.17M |
| 61 | RLAY | Relay Therapeutics, Inc. | 3.87B | 1.26% | 1,800,766 | 10.35M |
| 62 | TNGX | Tango Therapeutics, Inc. | 3.84B | -1.60% | 1,517,983 | 53.81M |
| 63 | XENE | Xenon Pharmaceuticals Inc. | 3.78B | 2.14% | 1,060,381 | 7.50M |
| 64 | PBLS | Parabilis Medicines, Inc. | 3.68B | 1.88% | 503,947 | 148.00K |
| 65 | IRON | Disc Medicine, Inc. | 3.67B | 1.85% | 251,203 | - |
| 66 | ACAD | Acadia Pharmaceuticals Inc. | 3.65B | 2.92% | 2,975,474 | 1.14B |
| 67 | VKTX | Viking Therapeutics, Inc. | 3.52B | 5.83% | 2,689,726 | - |
| 68 | DYN | Dyne Therapeutics, Inc. | 3.43B | 1.86% | 2,584,242 | - |
| 69 | ELVN | Enliven Therapeutics, Inc. | 3.42B | 4.15% | 572,238 | - |
| 70 | TLX | Telix Pharmaceuticals Limited | 3.36B | 6.53% | 459,942 | 890.79M |
| 71 | CELC | Celcuity Inc. | 3.35B | -1.72% | 645,177 | - |
| 72 | DNLI | Denali Therapeutics Inc. | 3.29B | 5.71% | 3,207,761 | 21.38M |
| 73 | VRDN | Viridian Therapeutics, Inc. | 3.21B | 12.80% | 7,960,312 | 26.31M |
| 74 | IDYA | IDEAYA Biosciences, Inc. | 3.04B | 0.67% | 689,892 | 36.54M |
| 75 | TARS | Tarsus Pharmaceuticals, Inc. | 3.03B | -4.97% | 1,430,833 | 682.20M |
| 76 | ZLAB | Zai Lab Limited | 2.83B | 3.69% | 546,381 | 449.61M |
| 77 | BEAM | Beam Therapeutics Inc. | 2.75B | 4.60% | 720,297 | 146.64M |
| 78 | RCUS | Arcus Biosciences, Inc. | 2.74B | 0.74% | 771,971 | 117.00M |
| 79 | MBX | MBX Biosciences, Inc. | 2.59B | -2.24% | 206,582 | - |
| 80 | XNCR | Xencor, Inc. | 2.54B | 11.29% | 1,663,833 | 104.97M |
| 81 | NAMS | NewAmsterdam Pharma Company N.V. | 2.49B | 4.57% | 1,367,703 | 25.94M |
| 82 | PHVS | Pharvaris N.V. | 2.39B | -1.93% | 186,368 | - |
| 83 | ADMA | ADMA Biologics, Inc. | 2.37B | -4.77% | 7,642,406 | 512.28M |
| 84 | PVLA | Palvella Therapeutics, Inc. | 2.32B | 5.47% | 243,717 | - |
| 85 | CLDX | Celldex Therapeutics, Inc. | 2.32B | -0.47% | 345,032 | 158.00K |
| 86 | BHVN | Biohaven Ltd. | 2.30B | -2.31% | 826,197 | - |
| 87 | RXRX | Recursion Pharmaceuticals, Inc. | 2.30B | 4.35% | 15,937,110 | 68.23M |
| 88 | VERA | Vera Therapeutics, Inc. | 2.29B | 3.45% | 1,165,888 | - |
| 89 | VCEL | Vericel Corporation | 2.28B | 8.59% | 987,320 | 306.30M |
| 90 | AUPH | Aurinia Pharmaceuticals Inc. | 2.28B | 2.84% | 981,022 | 321.74M |
| 91 | IMNM | Immunome, Inc. | 2.24B | -6.67% | 1,964,640 | 4.02M |
| 92 | ZYME | Zymeworks Inc. | 2.19B | 2.62% | 677,952 | 37.13M |
| 93 | LKFT | Lakefront Biotherapeutics NV | 2.17B | 5.38% | 285,141 | 1.13B |
| 94 | SEPN | Septerna, Inc. | 2.16B | 5.93% | 382,598 | 98.88M |
| 95 | TRAX | First Tracks Biotherapeutics, Inc. | 2.08B | 6.82% | 533,035 | - |
| 96 | COAG | Hemab Therapeutics Holdings, Inc. | 2.05B | 1.72% | 269,269 | - |
| 97 | HRMY | Harmony Biosciences Holdings, Inc. | 2.01B | -6.54% | 1,770,175 | 989.36M |
| 98 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.01B | 3.69% | 1,955,887 | 208.78M |
| 99 | TRVI | Trevi Therapeutics, Inc. | 2.00B | 1.44% | 752,123 | - |
| 100 | SRPT | Sarepta Therapeutics, Inc. | 2.00B | 2.27% | 740,387 | 1.97B |
| 101 | FTRE | Fortrea Holdings Inc. | 1.99B | -1.48% | 736,506 | 2.67B |
| 102 | VIR | Vir Biotechnology, Inc. | 1.96B | 3.30% | 1,316,876 | 303.23M |
| 103 | REPL | Replimune Group, Inc. | 1.94B | -0.68% | 2,259,377 | - |
| 104 | AGIO | Agios Pharmaceuticals, Inc. | 1.87B | 0.45% | 346,646 | 98.34M |
| 105 | ZBIO | Zenas BioPharma, Inc. | 1.84B | -0.32% | 339,555 | 1.00M |
| 106 | SLS | SELLAS Life Sciences Group, Inc. | 1.84B | 2.48% | 3,974,759 | - |
| 107 | MESO | Mesoblast Limited | 1.83B | -3.52% | 217,245 | 120.25M |
| 108 | MAZE | Maze Therapeutics, Inc. | 1.80B | 3.71% | 263,324 | 20.00M |
| 109 | GENB | Generate Biomedicines, Inc. | 1.79B | 0.51% | 369,278 | 26.48M |
| 110 | PGEN | Precigen, Inc. | 1.78B | -5.05% | 6,781,594 | 85.72M |
| 111 | STOK | Stoke Therapeutics, Inc. | 1.77B | 1.24% | 756,828 | 28.21M |
| 112 | NRIX | Nurix Therapeutics, Inc. | 1.75B | -37.90% | 15,093,705 | 701.94M |
| 113 | ABSI | Absci Corporation | 1.73B | 0.80% | 2,978,093 | 1.56M |
| 114 | NTLA | Intellia Therapeutics, Inc. | 1.72B | 3.71% | 1,767,211 | 59.51M |
| 115 | NVAX | Novavax, Inc. | 1.72B | 7.44% | 4,173,476 | 413.80M |
| 116 | ADRX | ADARx Pharmaceuticals, Inc. | 1.69B | -6.53% | 265,947 | 6.13M |
| 117 | RARE | Ultragenyx Pharmaceutical Inc. | 1.67B | 2.19% | 4,825,430 | 730.00M |
| 118 | BRVE | Braveheart Bio, Inc. | 1.63B | -6.64% | 493,446 | - |
| 119 | KLRA | Kailera Therapeutics, Inc. | 1.63B | -0.24% | 287,673 | - |
| 120 | NUVB | Nuvation Bio Inc. | 1.62B | -1.49% | 4,907,694 | 169.90M |
| 121 | LYCA | Lycia Therapeutics, Inc. | 1.60B | 0.31% | 132,103 | 4.44M |
| 122 | QURE | uniQure N.V. | 1.58B | -4.40% | 1,852,326 | 20.17M |
| 123 | OCUL | Ocular Therapeutix, Inc. | 1.55B | 3.81% | 2,409,783 | 52.06M |
| 124 | INVA | Innoviva, Inc. | 1.54B | 2.01% | 432,066 | 440.00M |
| 125 | RAPP | Rapport Therapeutics, Inc. | 1.53B | 1.45% | 559,350 | 20.00M |
| 126 | NBTX | Nanobiotix S.A. | 1.52B | 4.38% | 206,363 | 13.15M |
| 127 | IMCR | Immunocore Holdings plc | 1.48B | -4.01% | 358,069 | 430.78M |
| 128 | MLYS | Mineralys Therapeutics, Inc. | 1.48B | 4.57% | 1,127,029 | - |
| 129 | TYRA | Tyra Biosciences, Inc. | 1.47B | -0.28% | 333,729 | - |
| 130 | AAPG | Ascentage Pharma Group International | 1.45B | 8.83% | 18,723 | 94.61M |
| 131 | GPCR | Structure Therapeutics Inc. | 1.44B | -0.54% | 356,685 | - |
| 132 | KARD | Kardigan, Inc. | 1.42B | 5.73% | 275,585 | - |
| 133 | ANAB | AnaptysBio, Inc. | 1.40B | -1.59% | 266,394 | 106.09M |
| 134 | TSHA | Taysha Gene Therapies, Inc. | 1.40B | 5.26% | 1,927,374 | 5.49M |
| 135 | URGN | UroGen Pharma Ltd. | 1.39B | -17.19% | 2,270,533 | 250.25M |
| 136 | KRSA | Korsana Biosciences, Inc. | 1.38B | -5.35% | 98,604 | - |
| 137 | DMRA | Damora Therapeutics, Inc. | 1.38B | 0.91% | 372,552 | - |
| 138 | GHRS | GH Research PLC | 1.36B | -1.97% | 211,894 | - |
| 139 | OMER | Omeros Corporation | 1.31B | -0.66% | 530,083 | 38.42M |
| 140 | DRTS | Alpha Tau Medical Ltd. | 1.30B | 4.36% | 440,098 | - |
| 141 | NKTR | Nektar Therapeutics | 1.30B | 0.53% | 255,098 | 54.59M |
| 142 | LBRX | LB Pharmaceuticals Inc | 1.29B | -1.02% | 235,743 | - |
| 143 | MNKD | MannKind Corporation | 1.25B | 4.56% | 2,376,616 | 393.63M |
| 144 | INBX | Inhibrx Biosciences, Inc. | 1.24B | 4.20% | 122,130 | 1.30M |
| 145 | VOR | Vor Biopharma Inc. | 1.22B | -0.13% | 242,303 | - |
| 146 | SLN | Silence Therapeutics plc | 1.19B | 0.03% | 769,969 | 615.00K |
| 147 | VSTM | Verastem, Inc. | 1.19B | 0.31% | 1,771,640 | 87.53M |
| 148 | AVLN | Avalyn Pharma Inc. | 1.19B | -0.22% | 138,879 | - |
| 149 | SVRA | Savara Inc. | 1.18B | -2.53% | 2,619,062 | - |
| 150 | SGP | SpyGlass Pharma, Inc. | 1.14B | -1.34% | 153,560 | - |
| 151 | SPTX | Seaport Therapeutics, Inc. | 1.12B | 3.37% | 177,717 | - |
| 152 | JANX | Janux Therapeutics, Inc. | 1.09B | - | 705,593 | 24.00M |
| 153 | MLTX | MoonLake Immunotherapeutics | 969.37M | -2.65% | 831,875 | - |
| 154 | ORIC | ORIC Pharmaceuticals, Inc. | 969.15M | -2.50% | 2,174,006 | - |
| 155 | RIGL | Rigel Pharmaceuticals, Inc. | 951.93M | 4.30% | 141,551 | 276.79M |
| 156 | IMTX | Immatics N.V. | 945.21M | -2.26% | 392,719 | 47.65M |
| 157 | LTGO | Latigo Biotherapeutics, Inc. | 944.43M | -2.23% | 93,287 | - |
| 158 | JBIO | Jade Biosciences, Inc. | 941.88M | 1.65% | 680,636 | - |
| 159 | ODTX | Odyssey Therapeutics, Inc. | 933.93M | -9.64% | 490,241 | 99.00K |
| 160 | GLUE | Monte Rosa Therapeutics, Inc. | 918.83M | 3.46% | 1,062,394 | 28.73M |
| 161 | IVA | Inventiva S.A. | 916.65M | -2.48% | 1,266,494 | 2.81M |
| 162 | ANRO | Alto Neuroscience, Inc. | 911.01M | 2.27% | 250,648 | - |
| 163 | MGTX | MeiraGTx Holdings plc | 904.73M | -1.05% | 321,261 | 397.50M |
| 164 | SNDX | Syndax Pharmaceuticals, Inc. | 897.44M | -29.67% | 11,849,979 | 289.68M |
| 165 | PRME | Prime Medicine, Inc. | 885.96M | 9.45% | 3,328,054 | 4.07M |
| 166 | PHAR | Pharming Group N.V. | 879.78M | -0.08% | 26,724 | 386.75M |
| 167 | CRVS | Corvus Pharmaceuticals, Inc. | 877.80M | 6.15% | 807,830 | - |
| 168 | CTY | City Therapeutics, Inc. | 873.73M | -8.01% | 250,874 | 14.34M |
| 169 | ALMS | Alumis Inc. | 842.62M | 0.15% | 681,955 | 7.40M |
| 170 | AKTS | Aktis Oncology, Inc. | 834.29M | 0.40% | 129,290 | 10.06M |
| 171 | ANNX | Annexon, Inc. | 830.36M | 4.53% | 3,363,171 | - |
| 172 | BBTX | Bambusa Therapeutics, Inc. | 807.95M | -0.88% | 152,021 | - |
| 173 | ARDX | Ardelyx, Inc. | 806.12M | 6.77% | 6,758,098 | 468.22M |
| 174 | ABUS | Arbutus Biopharma Corporation | 798.32M | 3.99% | 1,314,014 | 181.72M |
| 175 | CGEM | Cullinan Therapeutics, Inc. | 779.34M | -23.11% | 1,509,995 | - |
| 176 | SANA | Sana Biotechnology, Inc. | 769.36M | 5.33% | 1,972,217 | - |
| 177 | DNA | Ginkgo Bioworks Holdings, Inc. | 746.80M | 3.07% | 1,643,810 | 132.42M |
| 178 | OABI | OmniAb, Inc. | 744.62M | -0.87% | 718,595 | 40.21M |
| 179 | ACHV | Achieve Life Sciences, Inc. | 725.98M | 4.83% | 824,475 | - |
| 180 | WVE | Wave Life Sciences, Inc. | 719.89M | 1.96% | 1,671,444 | 70.92M |
| 181 | SGMT | Sagimet Biosciences Inc. | 702.70M | -0.40% | 490,947 | - |
| 182 | ATTO | Attovia Therapeutics, Inc. | 702.12M | 0.72% | 151,655 | 1.80M |
| 183 | SLDB | Solid Biosciences Inc. | 689.46M | 2.39% | 695,237 | - |
| 184 | KURA | Kura Oncology, Inc. | 687.22M | -21.81% | 5,701,705 | 77.23M |
| 185 | CADL | Candel Therapeutics, Inc. | 683.31M | 1.25% | 639,790 | - |
| 186 | OBX | Obsidian Therapeutics, Inc. | 682.59M | -16.48% | 329,759 | - |
| 187 | AURA | Aura Biosciences, Inc. | 682.38M | 5.45% | 651,739 | - |
| 188 | FDMT | 4D Molecular Therapeutics, Inc. | 675.64M | 2.34% | 490,545 | 92.01M |
| 189 | SLBT | SL Science Holding Limited | 667.21M | -4.10% | 26,721 | 3.27M |
| 190 | LXRX | Lexicon Pharmaceuticals, Inc. | 665.21M | 2.40% | 835,767 | 41.47M |
| 191 | GERN | Geron Corporation | 664.96M | 11.29% | 20,557,938 | 217.52M |
| 192 | AVBP | ArriVent BioPharma, Inc. | 661.22M | 3.00% | 779,185 | - |
| 193 | DSGN | Design Therapeutics, Inc. | 659.61M | 1.93% | 152,191 | - |
| 194 | ZVRA | Zevra Therapeutics, Inc. | 652.63M | 7.12% | 1,414,635 | 147.76M |
| 195 | APMD | Apnimed, Inc. | 651.52M | 3.92% | 467,849 | 115.12M |
| 196 | OLMA | Olema Pharmaceuticals, Inc. | 648.36M | 0.82% | 753,792 | - |
| 197 | IMMX | Immix Biopharma, Inc. | 644.98M | 0.91% | 754,657 | - |
| 198 | IAM | Iambic Therapeutics, Inc. | 637.07M | -0.37% | 233,454 | 18.25M |
| 199 | HELP | Helus Pharma Inc. | 631.61M | -4.26% | 829,144 | - |
| 200 | DBVT | DBV Technologies S.A. | 606.92M | -2.42% | 216,564 | 3.74M |
| 201 | ANL | Adlai Nortye Group Ltd. | 598.58M | -2.97% | 69,712 | 18.06M |
| 202 | BCAX | Bicara Therapeutics Inc. | 586.95M | -1.00% | 491,381 | - |
| 203 | CBIO | Crescent Biopharma, Inc. | 580.38M | 3.83% | 68,749 | 11.88M |
| 204 | NVCT | Nuvectis Pharma, Inc. | 578.00M | -8.27% | 206,768 | - |
| 205 | DMAC | DiaMedica Therapeutics Inc. | 577.00M | 7.00% | 308,747 | - |
| 206 | ACRS | Aclaris Therapeutics, Inc. | 565.69M | -2.41% | 1,223,149 | 8.22M |
| 207 | VALN | Valneva SE | 558.46M | 3.64% | 5,780 | 163.30M |
| 208 | PBYI | Puma Biotechnology, Inc. | 552.33M | 4.70% | 284,148 | 231.24M |
| 209 | NGNE | Neurogene Inc. | 548.41M | 2.76% | 90,781 | 925.00K |
| 210 | SRZN | Surrozen, Inc. | 545.50M | 3.52% | 151,286 | 11.51M |
| 211 | ENTX | Entera Bio Ltd. | 544.38M | 2.62% | 122,469 | 42.00K |
| 212 | CLYM | Climb Bio, Inc. | 531.29M | -5.13% | 451,341 | - |
| 213 | STTK | Shattuck Labs, Inc. | 523.90M | -4.57% | 371,086 | 1.00M |
| 214 | OVID | Ovid Therapeutics Inc. | 513.63M | 9.58% | 1,285,948 | 1.58M |
| 215 | RGNX | REGENXBIO Inc. | 508.30M | 0.92% | 617,928 | 174.48M |
| 216 | FTH | Faeth Therapeutics, Inc. | 504.15M | -0.71% | 165,522 | - |
| 217 | CAPR | Capricor Therapeutics, Inc. | 504.07M | 5.22% | 4,408,510 | 11.13M |
| 218 | CTMX | CytomX Therapeutics, Inc. | 495.72M | 4.36% | 3,343,342 | 18.30M |
| 219 | INDP | Indaptus Therapeutics, Inc. | 489.92M | -1.54% | 89,903 | - |
| 220 | ETRA | Electra Therapeutics, Inc. | 487.07M | -3.84% | 271,523 | - |
| 221 | ARVN | Arvinas, Inc. | 482.55M | 4.09% | 656,124 | 275.30M |
| 222 | MNPR | Monopar Therapeutics Inc. | 481.73M | 2.69% | 157,156 | - |
| 223 | YDES | YD Bio Limited | 480.94M | 6.18% | 48,232 | 1.24M |
| 224 | GYRE | Gyre Therapeutics, Inc. | 467.61M | -0.68% | 209,757 | 109.82M |
| 225 | MDXG | MiMedx Group, Inc. | 462.58M | -2.46% | 1,095,017 | 303.73M |
| 226 | RLMD | Relmada Therapeutics, Inc. | 456.55M | 0.23% | 1,596,294 | - |
| 227 | PHAT | Phathom Pharmaceuticals, Inc. | 455.13M | -0.17% | 1,035,586 | 274.88M |
| 228 | OCS | Oculis Holding AG | 446.94M | -5.11% | 389,734 | 1.12M |
| 229 | EPRX | Eupraxia Pharmaceuticals Inc. | 442.85M | -2.54% | 356,383 | - |
| 230 | CRMD | CorMedix Inc. | 439.61M | 1.44% | 983,498 | 462.25M |
| 231 | PRTA | Prothena Corporation plc | 431.23M | 2.31% | 153,294 | 54.53M |
| 232 | PRLD | Prelude Therapeutics Incorporated | 423.31M | 8.73% | 293,453 | 22.42M |
| 233 | RZLT | Rezolute, Inc. | 418.54M | -0.50% | 700,786 | - |
| 234 | EDIT | Editas Medicine, Inc. | 413.13M | 3.46% | 1,686,012 | 47.01M |
| 235 | ALT | Altimmune, Inc. | 408.49M | 2.94% | 2,213,655 | 31.00K |
| 236 | ASMB | Assembly Biosciences, Inc. | 402.12M | -0.85% | 140,719 | 74.85M |
| 237 | ALLO | Allogene Therapeutics, Inc. | 399.04M | 3.12% | 13,302,730 | 4.64M |
| 238 | TECX | Tectonic Therapeutic, Inc. | 392.06M | 5.66% | 146,111 | - |
| 239 | CCCC | C4 Therapeutics, Inc. | 387.53M | -1.87% | 1,378,598 | 35.04M |
| 240 | ZURA | Zura Bio Limited | 387.23M | 0.75% | 1,444,537 | - |
| 241 | BLSM | BlossomHill Therapeutics, Inc. | 374.43M | -5.08% | 212,583 | - |
| 242 | AVTX | Avalo Therapeutics, Inc. | 374.34M | -3.72% | 847,060 | 59.00K |
| 243 | MPLT | MapLight Therapeutics, Inc. | 374.30M | -1.10% | 246,388 | - |
| 244 | LYEL | Lyell Immunopharma, Inc. | 371.74M | 40.85% | 969,599 | 27.00K |
| 245 | FENC | Fennec Pharmaceuticals Inc. | 366.80M | -2.24% | 78,070 | 59.22M |
| 246 | AUTL | Autolus Therapeutics plc | 365.97M | -2.83% | 2,247,452 | 117.39M |
| 247 | OBIO | Orchestra BioMed Holdings, Inc. | 361.83M | 8.27% | 216,164 | 31.98M |
| 248 | CTNM | Contineum Therapeutics, Inc. | 360.79M | -1.03% | 603,575 | - |
| 249 | AVIR | Atea Pharmaceuticals, Inc. | 358.52M | 7.19% | 142,486 | - |
| 250 | GALT | Galectin Therapeutics Inc. | 352.97M | 4.48% | 158,279 | - |
| 251 | TRXB | TRex Bio, Inc. | 352.14M | -4.73% | 86,684 | - |
| 252 | IRD | Opus Genetics, Inc. | 350.25M | 7.12% | 799,323 | 9.86M |
| 253 | ASPE | Aspen Neuroscience, Inc. | 344.76M | -3.53% | 137,559 | - |
| 254 | AGMB | AgomAb Therapeutics NV | 343.26M | 1.75% | 52,919 | - |
| 255 | PROK | ProKidney Corp. | 340.11M | 5.14% | 993,612 | 818.00K |
| 256 | EIKN | Eikon Therapeutics, Inc. | 339.61M | 12.97% | 427,277 | - |
| 257 | ALEC | Alector, Inc. | 335.80M | 10.49% | 1,172,278 | 13.86M |
| 258 | SCTX | Scribe Therapeutics Inc. | 323.73M | 5.56% | 217,585 | 33.30M |
| 259 | BNTC | Benitec Biopharma Inc. | 319.18M | 8.93% | 135,320 | - |
| 260 | KYTX | Kyverna Therapeutics, Inc. | 317.57M | -0.48% | 690,198 | - |
| 261 | XFOR | X4 Pharmaceuticals, Inc. | 316.77M | 0.79% | 275,324 | 15.85M |
| 262 | ENTA | Enanta Pharmaceuticals, Inc. | 311.93M | 3.28% | 162,040 | 65.26M |
| 263 | AGEN | Agenus Inc. | 311.54M | 3.75% | 547,204 | 132.69M |
| 264 | IPSC | Century Therapeutics, Inc. | 305.11M | 10.86% | 511,431 | 109.16M |
| 265 | SPRY | ARS Pharmaceuticals, Inc. | 303.31M | - | 1,727,372 | 116.93M |
| 266 | ARCT | Arcturus Therapeutics Holdings Inc. | 299.44M | 10.43% | 304,744 | 29.37M |
| 267 | VTVT | vTv Therapeutics Inc. | 298.44M | 2.00% | 23,978 | 36.84M |
| 268 | NAUT | Nautilus Biotechnology, Inc. | 292.96M | -2.13% | 5,438,835 | 424.00K |
| 269 | TTRX | Turn Therapeutics Inc. | 290.58M | 2.58% | 72,113 | - |
| 270 | VOGX | Vogenx, Inc. | 289.96M | -4.92% | 113,067 | - |
| 271 | FULC | Fulcrum Therapeutics, Inc. | 286.88M | 0.53% | 596,622 | 80.00M |
| 272 | OCGN | Ocugen, Inc. | 286.62M | 13.42% | 6,968,729 | 4.78M |
| 273 | IKT | Inhibikase Therapeutics, Inc. | 285.86M | 6.08% | 481,385 | 1.00 |
| 274 | LRMR | Larimar Therapeutics, Inc. | 283.92M | 7.09% | 1,703,201 | - |
| 275 | SABS | SAB Biotherapeutics, Inc. | 283.88M | - | 765,325 | 114.70K |
| 276 | RCKT | Rocket Pharmaceuticals, Inc. | 279.93M | 1.59% | 1,150,101 | - |
| 277 | VCRE | Vicore Pharma Holding AB (publ) | 275.41M | 3.71% | 12,929 | 412.09K |
| 278 | QTTB | Q32 Bio Inc. | 265.25M | 1.71% | 135,155 | 53.74M |
| 279 | LXEO | Lexeo Therapeutics, Inc. | 262.95M | 3.05% | 870,679 | - |
| 280 | LCTX | Lineage Cell Therapeutics, Inc. | 261.76M | 2.48% | 710,196 | 13.08M |
| 281 | BCYC | Bicycle Therapeutics plc | 259.00M | 0.68% | 162,672 | 83.53M |
| 282 | FATE | Fate Therapeutics, Inc. | 247.43M | 1.23% | 486,522 | 6.49M |
| 283 | CUVL | Clinuvel Pharmaceuticals Limited | 245.16M | -1.48% | 613 | 65.05M |
| 284 | KRRO | Korro Bio, Inc. | 245.03M | 4.92% | 187,132 | 2.38M |
| 285 | IMRX | Immuneering Corporation | 244.16M | 2.45% | 454,695 | - |
| 286 | CABA | Cabaletta Bio, Inc. | 242.45M | 0.70% | 2,386,551 | - |
| 287 | ABEO | Abeona Therapeutics Inc. | 241.60M | -0.59% | 585,693 | 25.52M |
| 288 | GLSI | Greenwich LifeSciences, Inc. | 239.25M | 2.39% | 96,479 | - |
| 289 | CAMP | Camp4 Therapeutics Corporation | 237.21M | -1.31% | 85,315 | 4.22M |
| 290 | VNDA | Vanda Pharmaceuticals Inc. | 230.39M | 1.60% | 809,096 | 229.28M |
| 291 | DRUG | Bright Minds Biosciences Inc. | 226.77M | -13.23% | 359,069 | - |
| 292 | ACIU | AC Immune SA | 223.71M | 7.66% | 174,328 | 23.75M |
| 293 | ELDN | Eledon Pharmaceuticals, Inc. | 222.47M | 4.39% | 351,845 | - |
| 294 | SLGL | Sol-Gel Technologies Ltd. | 219.69M | 5.16% | 27,895 | 1.80M |
| 295 | EVMN | Evommune, Inc. | 217.21M | 0.76% | 135,751 | 10.00M |
| 296 | PLX | Protalix BioTherapeutics, Inc. | 217.14M | 3.26% | 734,415 | 80.62M |
| 297 | KROS | Keros Therapeutics, Inc. | 216.91M | 1.02% | 87,550 | 15.01M |
| 298 | DTIL | Precision BioSciences, Inc. | 215.62M | 12.08% | 298,505 | 45.04M |
| 299 | PALI | Palisade Bio, Inc. | 215.22M | 0.41% | 1,333,208 | 500.00K |
| 300 | ARTV | Artiva Biotherapeutics, Inc. | 204.36M | -0.48% | 510,086 | 251.00K |
| 301 | RNAC | Cartesian Therapeutics, Inc. | 203.62M | 4.99% | 44,818 | 1.48M |
| 302 | UPB | Upstream Bio, Inc. | 202.11M | 8.85% | 917,582 | 3.16M |
| 303 | IFRX | InflaRx N.V. | 201.89M | -15.43% | 1,316,353 | -38.53K |
| 304 | PRQR | ProQR Therapeutics N.V. | 200.39M | 3.65% | 597,298 | 21.05M |
| 305 | CGEN | Compugen Ltd. | 191.82M | 0.75% | 58,712 | 74.00M |
| 306 | PYXS | Pyxis Oncology, Inc. | 189.93M | -3.05% | 577,438 | 11.04M |
| 307 | ALXO | ALX Oncology Holdings Inc. | 188.06M | 5.43% | 665,791 | - |
| 308 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 187.61M | 0.86% | 338,321 | - |
| 309 | IVVD | Invivyd, Inc. | 186.73M | 8.94% | 3,628,155 | 58.37M |
| 310 | ACOG | Alpha Cognition Inc. | 185.11M | 3.66% | 151,675 | 15.26M |
| 311 | MDWD | MediWound Ltd. | 182.16M | 5.38% | 247,852 | 11.86M |
| 312 | WHWK | Whitehawk Therapeutics, Inc. | 178.72M | 1.13% | 331,695 | 7.15M |
| 313 | PEPG | PepGen Inc. | 178.69M | 4.88% | 1,149,468 | - |
| 314 | TRDA | Entrada Therapeutics, Inc. | 177.40M | 4.24% | 264,906 | 4.69M |
| 315 | CNTN | Canton Strategic Holdings, Inc. | 172.11M | 10.77% | 376,427 | 1.50M |
| 316 | ORMP | Oramed Pharmaceuticals Inc. | 170.13M | 2.25% | 70,110 | 2.00M |
| 317 | INO | Inovio Pharmaceuticals, Inc. | 166.47M | -3.01% | 18,635,497 | 65.34K |
| 318 | ZNTL | Zentalis Pharmaceuticals, Inc. | 164.73M | -2.25% | 750,968 | 26.87M |
| 319 | SION | Sionna Therapeutics, Inc. | 164.57M | -0.27% | 416,143 | - |
| 320 | STRO | Sutro Biopharma, Inc. | 160.17M | 1.58% | 81,232 | 45.70M |
| 321 | ANTX | AN2 Therapeutics, Inc. | 158.11M | 0.24% | 72,960 | - |
| 322 | ADAG | Adagene Inc. | 157.79M | - | 55,436 | 9.29M |
| 323 | RNA | Atrium Therapeutics, Inc. | 147.96M | -0.80% | 79,013 | 35.84M |
| 324 | MGNX | MacroGenics, Inc. | 147.47M | -0.64% | 701,680 | 175.14M |
| 325 | IPHA | Innate Pharma S.A. | 145.74M | 10.53% | 10,464 | 11.21M |
| 326 | NGEN | NervGen Pharma Corp. | 144.08M | 1.52% | 141,337 | - |
| 327 | TARA | Protara Therapeutics, Inc. | 140.65M | -1.24% | 194,599 | - |
| 328 | CMPX | Compass Therapeutics, Inc. | 138.96M | 2.47% | 1,001,228 | 850.00K |
| 329 | YARW | Yarrow Bioscience, Inc. | 138.45M | -19.00% | 60,973 | - |
| 330 | VRXA | Veraxa Biotech AG | 137.43M | -1.83% | 82,213 | 29.54K |
| 331 | MSLE | Satellos Bioscience Inc. | 136.86M | 0.31% | 9,846 | - |
| 332 | CUE | Cue Biopharma, Inc. | 134.39M | -11.31% | 24,552 | 37.66M |
| 333 | CHRS | Coherus Oncology, Inc. | 132.99M | 6.85% | 1,650,653 | 50.94M |
| 334 | MOLN | Molecular Partners AG | 129.22M | 6.47% | 1,739 | 856.30K |
| 335 | SPRB | Spruce Biosciences, Inc. | 129.07M | 4.91% | 36,683 | 697.00K |
| 336 | MENS | Jyong Biotech Ltd. | 125.83M | -4.78% | 70,475 | - |
| 337 | FHTX | Foghorn Therapeutics Inc. | 125.30M | -0.94% | 387,595 | 36.74M |
| 338 | NERV | Minerva Neurosciences, Inc. | 124.62M | 11.06% | 168,284 | - |
| 339 | HUMA | Humacyte, Inc. | 123.26M | 0.73% | 2,179,774 | 2.12M |
| 340 | NKTX | Nkarta, Inc. | 121.76M | 11.11% | 1,459,474 | - |
| 341 | NBP | NovaBridge Biosciences | 119.48M | 1.98% | 203,357 | - |
| 342 | AVXL | Anavex Life Sciences Corp. | 118.19M | 6.25% | 248,813 | - |
| 343 | CDXS | Codexis, Inc. | 117.17M | -0.93% | 470,649 | 77.68M |
| 344 | ARMP | Armata Pharmaceuticals, Inc. | 116.38M | 1.29% | 43,684 | 5.54M |
| 345 | PYPD | PolyPid Ltd. | 115.98M | 4.58% | 139,916 | - |
| 346 | VYGR | Voyager Therapeutics, Inc. | 114.61M | 1.64% | 501,227 | 34.46M |
| 347 | ENGN | enGene Therapeutics Inc. | 113.93M | 4.94% | 1,121,786 | - |
| 348 | OTLK | Outlook Therapeutics, Inc. | 112.89M | 0.80% | 2,193,420 | -1.16M |
| 349 | EQ | Equillium, Inc. | 110.50M | - | 125,919 | 4.39M |
| 350 | ANIX | Anixa Biosciences, Inc. | 109.85M | 3.44% | 113,626 | - |
| 351 | MIST | Milestone Pharmaceuticals Inc. | 109.49M | 2.33% | 541,746 | 2.34M |
| 352 | BDTX | Black Diamond Therapeutics, Inc. | 108.59M | 4.42% | 509,693 | 70.00M |
| 353 | KZIA | Kazia Therapeutics Limited | 108.26M | -2.23% | 183,445 | 1.27M |
| 354 | NMRA | Neumora Therapeutics, Inc. | 107.83M | 0.53% | 1,885,989 | - |
| 355 | HURA | TuHURA Biosciences, Inc. | 107.70M | 2.11% | 379,945 | - |
| 356 | LENZ | LENZ Therapeutics, Inc. | 107.46M | -2.29% | 929,065 | 12.36M |
| 357 | NRXP | NRx Pharmaceuticals, Inc. | 106.43M | 9.82% | 831,939 | 3.39M |
| 358 | IMUX | Immunic, Inc. | 105.95M | 2.17% | 127,325 | - |
| 359 | OKUR | OnKure Therapeutics, Inc. | 104.28M | 3.00% | 426,147 | - |
| 360 | UNCY | Unicycive Therapeutics, Inc. | 102.93M | 2.92% | 341,608 | - |
| 361 | TENX | Tenax Therapeutics, Inc. | 101.39M | -3.80% | 970,534 | - |
| 362 | PMVP | PMV Pharmaceuticals, Inc. | 99.68M | -4.35% | 479,331 | - |
| 363 | RTSN | Retension Pharmaceuticals, Inc. | 97.48M | -0.76% | 132,098 | - |
| 364 | VANI | Vivani Medical, Inc. | 95.62M | 0.95% | 164,601 | - |
| 365 | SEER | Seer, Inc. | 94.96M | -0.87% | 38,253 | 14.22M |
| 366 | ICCC | ImmuCell Corporation | 94.18M | 1.17% | 4,189 | 30.68M |
| 367 | PDSB | PDS Biotechnology Corporation | 92.04M | -9.93% | 3,971,174 | - |
| 368 | PLYX | Polaryx Therapeutics, Inc. | 89.72M | 4.05% | 10,154 | - |
| 369 | CBUS | Cibus, Inc. | 89.04M | 2.19% | 60,838 | 4.35M |
| 370 | TVGN | Tevogen Inc. | 88.12M | -5.41% | 1,686 | - |
| 371 | TNXP | Tonix Pharmaceuticals Holding Corp. | 87.47M | -1.73% | 279,272 | 29.10M |
| 372 | RLYB | Rallybio Corporation | 86.63M | 1.45% | 52,813 | 434.00K |
| 373 | CLLS | Cellectis S.A. | 86.18M | 2.75% | 5,981 | 63.82M |
| 374 | ATRA | Atara Biotherapeutics, Inc. | 83.92M | 1.95% | 7,848 | 6.19M |
| 375 | GNLX | Genelux Corporation | 83.80M | -2.60% | 125,126 | 8.00K |
| 376 | TNYA | Tenaya Therapeutics, Inc. | 83.19M | 2.97% | 1,141,960 | 1.34M |
| 377 | NRXS | NeurAxis, Inc. | 83.01M | 0.46% | 30,797 | 5.32M |
| 378 | TLSA | Tiziana Life Sciences Ltd | 80.80M | -8.55% | 349,208 | - |
| 379 | RANI | Rani Therapeutics Holdings, Inc. | 80.65M | 4.10% | 197,223 | 4.88M |
| 380 | NTHI | NeOnc Technologies Holdings, Inc. | 76.56M | 0.33% | 30,867 | 39.99K |
| 381 | NTRB | Nutriband Inc. | 74.39M | -2.70% | 18,959 | 1.62M |
| 382 | OKYO | OKYO Pharma Limited | 73.47M | -3.45% | 80,863 | - |
| 383 | ACRV | Acrivon Therapeutics, Inc. | 73.28M | 2.40% | 107,243 | - |
| 384 | COYA | Coya Therapeutics, Inc. | 71.78M | -1.61% | 159,408 | 8.02M |
| 385 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 71.37M | -4.65% | 1,609,884 | - |
| 386 | MNOV | MediciNova, Inc. | 70.88M | 1.41% | 2,830 | 920.48K |
| 387 | CRDF | Cardiff Oncology, Inc. | 67.74M | 0.89% | 228,977 | 508.00K |
| 388 | CNXU | Conexeu Sciences Inc. | 67.68M | -7.77% | 154,568 | - |
| 389 | MAIA | MAIA Biotechnology, Inc. | 67.52M | 2.78% | 218,403 | - |
| 390 | CSBR | Champions Oncology, Inc. | 66.95M | -0.41% | 2,351 | 60.66M |
| 391 | CGTX | Cognition Therapeutics, Inc. | 65.63M | -1.33% | 362,124 | - |
| 392 | CING | Cingulate Inc. | 65.58M | -4.45% | 83,301 | - |
| 393 | FBIO | Fortress Biotech, Inc. | 65.37M | 1.03% | 98,109 | 68.47M |
| 394 | TELO | Telomir Pharmaceuticals, Inc. | 63.30M | -5.51% | 111,950 | - |
| 395 | SPRO | Spero Therapeutics, Inc. | 62.31M | 2.88% | 190,641 | 47.00M |
| 396 | VRCA | Verrica Pharmaceuticals Inc. | 60.13M | 6.38% | 23,374 | 30.32M |
| 397 | GOSS | Gossamer Bio, Inc. | 60.00M | 5.71% | 84,550 | 53.29M |
| 398 | XBIT | XBiotech Inc. | 59.15M | -2.51% | 88,430 | - |
| 399 | XLO | Xilio Therapeutics, Inc. | 57.97M | 1.50% | 9,454 | 64.09M |
| 400 | RNXT | RenovoRx, Inc. | 57.77M | -0.78% | 168,528 | 1.98M |
| 401 | CLNN | Clene Inc. | 57.71M | 7.69% | 88,705 | 238.00K |
| 402 | RNTX | Rein Therapeutics Inc. | 57.13M | -0.78% | 206,689 | - |
| 403 | BOLD | Boundless Bio, Inc. | 55.50M | 2.52% | 129,037 | - |
| 404 | HRTX | Heron Therapeutics, Inc. | 54.62M | 1.05% | 655,461 | 151.18M |
| 405 | INKT | MiNK Therapeutics, Inc. | 54.09M | -1.76% | 3,732 | - |
| 406 | ONCY | Oncolytics Biotech Inc. | 53.82M | 8.23% | 769,225 | - |
| 407 | ALPS | Alps Group Inc | 53.24M | -0.02% | 34,119 | 3.74M |
| 408 | IBIO | iBio, Inc. | 52.89M | -0.12% | 201,933 | 100.00K |
| 409 | PLRX | Pliant Therapeutics, Inc. | 52.54M | -1.41% | 140,929 | - |
| 410 | ELOX | Eloxx Pharmaceuticals, Inc. | 51.91M | -0.46% | 8,017 | - |
| 411 | OSTX | OS Therapies Incorporated | 51.75M | -3.45% | 408,589 | - |
| 412 | HOWL | Werewolf Therapeutics, Inc. | 51.52M | -0.93% | 134,682 | 21.00M |
| 413 | ANVS | Annovis Bio, Inc. | 51.13M | 10.09% | 912,856 | - |
| 414 | KLRS | Kalaris Therapeutics, Inc. | 50.94M | 4.39% | 20,022 | - |
| 415 | HYFT | MindWalk Holdings Corp. | 49.94M | -3.64% | 1,199,829 | 11.57M |
| 416 | CNTB | Connect Biopharma Holdings Limited | 49.74M | 2.04% | 199,306 | 2.95M |
| 417 | GANX | Gain Therapeutics, Inc. | 48.88M | -2.61% | 168,925 | - |
| 418 | MREO | Mereo BioPharma Group plc | 48.11M | 3.54% | 491,101 | 500.00K |
| 419 | HYPD | Hyperion DeFi, Inc. | 48.02M | 1.31% | 79,882 | 1.40M |
| 420 | CRBU | Caribou Biosciences, Inc. | 47.79M | -2.97% | 852,197 | 10.04M |
| 421 | TIL | Instil Bio, Inc. | 47.34M | 4.65% | 24,773 | - |
| 422 | ATHE | Alterity Therapeutics Limited | 47.06M | 1.62% | 103,826 | 2.50M |
| 423 | IMA | ImageneBio, Inc. | 45.63M | - | 3,497 | 800.00K |
| 424 | BMEA | Biomea Fusion, Inc. | 44.44M | -1.72% | 699,721 | - |
| 425 | ATNM | Actinium Pharmaceuticals, Inc. | 44.27M | 0.57% | 99,378 | 35.09M |
| 426 | LONA | LeonaBio, Inc. | 43.53M | -3.14% | 72,969 | - |
| 427 | ELTX | Elicio Therapeutics, Inc. | 41.92M | 4.93% | 206,261 | - |
| 428 | APLM | Apollomics, Inc. | 41.72M | -8.83% | 45,261 | 8.84M |
| 429 | SER | Serina Therapeutics, Inc. | 41.15M | -11.48% | 27,142 | 130.00K |
| 430 | EXOZ | eXoZymes, Inc. | 40.84M | -7.37% | 11,655 | -700.00 |
| 431 | INMB | INmune Bio Inc. | 39.67M | -2.27% | 53,949 | 50.00K |
| 432 | GRDX | GridAI Technologies Corp. | 39.30M | 14.91% | 122,972 | - |
| 433 | ALDX | Aldeyra Therapeutics, Inc. | 38.87M | 3.81% | 913,792 | - |
| 434 | PTHS | Pelthos Therapeutics Inc. | 38.86M | -5.84% | 32,686 | 43.30M |
| 435 | GRCE | Grace Therapeutics, Inc. | 37.86M | -2.17% | 48,012 | - |
| 436 | VERU | Veru Inc. | 37.51M | 1.85% | 142,219 | 16.89M |
| 437 | NNVC | NanoViricides, Inc. | 35.99M | -1.40% | 71,064 | - |
| 438 | IBO | Impact BioMedical Inc. | 34.69M | 1.00% | 22,912 | 35.00K |
| 439 | DWTX | Dogwood Therapeutics, Inc. | 34.68M | -1.91% | 114,187 | - |
| 440 | LITS | Lite Strategy, Inc. | 33.75M | 6.73% | 118,668 | - |
| 441 | EYPT | EyePoint, Inc. | 33.06M | -4.10% | 1,919,648 | 2.79M |
| 442 | ACET | Adicet Bio, Inc. | 32.78M | -3.94% | 237,083 | - |
| 443 | IRLA | IRulya Therapeutics Inc. | 32.24M | -4.40% | 42,150 | - |
| 444 | ALGS | Aligos Therapeutics, Inc. | 31.10M | 4.84% | 25,712 | 31.52M |
| 445 | BYSI | BeyondSpring Inc. | 29.96M | 17.34% | 154,296 | 1.88M |
| 446 | MGX | Metagenomi Therapeutics, Inc. | 29.84M | 3.95% | 25,800 | 13.56M |
| 447 | EDSA | Edesa Biotech, Inc. | 29.66M | -3.73% | 38,899 | - |
| 448 | PMN | ProMIS Neurosciences, Inc. | 29.59M | -3.23% | 362,455 | - |
| 449 | PLRZ | Polyrizon Ltd. | 27.32M | -1.36% | 3,668 | - |
| 450 | BCTX | BriaCell Therapeutics Corp. | 27.32M | 4.65% | 59,578 | - |
| 451 | CELU | Celularity Inc. | 27.26M | 2.80% | 57,278 | 18.67M |
| 452 | RNAZ | TransCode Therapeutics, Inc. | 27.26M | 2.55% | 2,743 | - |
| 453 | FLNA | Filana Therapeutics, Inc. | 27.19M | -5.30% | 394,132 | - |
| 454 | NXTC | NextCure, Inc. | 27.03M | -0.08% | 31,559 | - |
| 455 | AARD | Aardvark Therapeutics, Inc. | 26.81M | -0.41% | 127,459 | - |
| 456 | EVAX | Evaxion A/S | 25.00M | 1.28% | 24,530 | 7.49M |
| 457 | ABVC | ABVC BioPharma, Inc. | 24.93M | -2.54% | 27,653 | 797.92K |
| 458 | CVM | CEL-SCI Corporation | 24.80M | - | 22,494 | - |
| 459 | CRVO | CervoMed Inc. | 22.83M | -2.58% | 350,516 | 331.30K |
| 460 | ATOS | Atossa Therapeutics, Inc. | 21.50M | -7.52% | 55,862 | - |
| 461 | IMMP | Immutep Limited | 21.27M | -1.84% | 4,419 | 13.79M |
| 462 | BSEM | BioStem Technologies, Inc. | 20.81M | -2.61% | 159,492 | 34.59M |
| 463 | AKTX | Akari Therapeutics, Plc | 20.45M | 9.81% | 84,652 | - |
| 464 | IGC | IGC Pharma, Inc. | 20.04M | 4.19% | 224,070 | 1.11M |
| 465 | ACTU | Actuate Therapeutics, Inc. | 20.02M | 4.00% | 192,158 | - |
| 466 | COCP | Cocrystal Pharma, Inc. | 19.65M | -4.67% | 20,457 | 330.00K |
| 467 | ESLA | Estrella Immunopharma, Inc. | 19.18M | 5.50% | 70,865 | - |
| 468 | CNTX | Context Therapeutics Inc. | 19.03M | 6.75% | 1,004,897 | - |
| 469 | QNRX | Quoin Pharmaceuticals, Ltd. | 18.98M | 0.51% | 6,307 | - |
| 470 | QNTM | Quantum BioPharma Ltd. | 18.97M | 1.36% | 36,168 | - |
| 471 | MCRB | Seres Therapeutics, Inc. | 18.95M | -3.77% | 56,430 | 2.13M |
| 472 | ALLR | Allarity Therapeutics, Inc. | 17.34M | -3.54% | 134,059 | 345.00K |
| 473 | MRKR | Marker Therapeutics, Inc. | 17.01M | 3.77% | 86,472 | 3.55M |
| 474 | KYNB | Kyntra Bio, Inc. | 16.76M | -3.94% | 11,886 | 4.62M |
| 475 | KTTA | Pasithea Therapeutics Corp. | 16.71M | -5.66% | 2,173,519 | - |
| 476 | JSPR | Jasper Therapeutics, Inc. | 16.64M | 4.17% | 618,771 | - |
| 477 | BOLT | Bolt Biotherapeutics, Inc. | 16.29M | -4.11% | 16,697 | 4.70M |
| 478 | NEUP | Neuphoria Therapeutics Inc. | 16.23M | 0.33% | 55,158 | 1.17M |
| 479 | ABOS | Acumen Pharmaceuticals, Inc. | 16.05M | -5.33% | 7,522,485 | - |
| 480 | CTXR | Citius Pharmaceuticals, Inc. | 15.26M | -3.03% | 121,333 | 7.11M |
| 481 | PLUR | Pluri Inc. | 15.06M | -3.94% | 10,439 | 1.02M |
| 482 | ATYR | aTyr Pharma, Inc. | 14.72M | -9.43% | 21,286 | 190.00K |
| 483 | BCDA | BioCardia, Inc. | 14.38M | 3.08% | 78,860 | 3.00K |
| 484 | NCEL | NewcelX Ltd. | 14.09M | -7.58% | 269,079 | - |
| 485 | TCRX | TScan Therapeutics, Inc. | 13.64M | 6.51% | 464,241 | 7.11M |
| 486 | DYAI | Dyadic International, Inc. | 13.45M | 2.56% | 37,083 | 3.80M |
| 487 | DARE | Daré Bioscience, Inc. | 13.38M | 4.65% | 189,355 | 1.37M |
| 488 | GUTS | Fractyl Health, Inc. | 13.00M | 9.11% | 38,186 | 3.00K |
| 489 | HIND | Vyome Holdings, Inc. | 12.11M | -2.50% | 7,048 | 129.73K |
| 490 | CLRB | Cellectar Biosciences, Inc. | 12.10M | -2.29% | 74,654 | - |
| 491 | LPCN | Lipocine Inc. | 12.04M | - | 45,591 | 1.57M |
| 492 | PBM | Psyence Biomedical Ltd. | 11.86M | -5.47% | 13,755 | - |
| 493 | TVRD | Tvardi Therapeutics, Inc. | 11.80M | 5.96% | 34,445 | - |
| 494 | PASG | Passage Bio, Inc. | 11.21M | 2.50% | 24,602 | - |
| 495 | AEON | AEON Biopharma, Inc. | 11.08M | 4.69% | 6,044,274 | - |
| 496 | INTS | Intensity Therapeutics, Inc. | 11.07M | 0.30% | 3,981 | - |
| 497 | ICU | SeaStar Medical Holding Corporation | 10.73M | 2.00% | 94,035 | 1.71M |
| 498 | PPBT | Purple Biotech Ltd | 10.57M | 0.85% | 44,979 | - |
| 499 | KPRX | Kiora Pharmaceuticals, Inc. | 10.44M | -5.20% | 8,858 | 20.00K |
| 500 | GDTC | CytoMed Therapeutics Limited | 10.36M | -4.63% | 2,003 | 609.73K |